Kopran Ltd.

•
₹ 196.09-1.82%

2026-08-21

kopran.comBSE: 524280NSE: KOPRAN
Market Cap₹ 985 Cr.
Current Price₹ 200
High / Low₹ 219 / 107
Stock P/E39.4
Book Value₹ 111
Price to Book0.99
Dividend Yield1.47 %
ROCE6.6 %
ROE4.9 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Bulk Drugs: 55.3% • Tablet / Capsules / Liquids: 44.3% • Others: 0.5%

PROS

  • Company has consistently been profitable over the last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.32x)
  • Company has been maintaining a healthy dividend payout of 56.3%
  • Working capital cycle has improved - days down from 128 to 95
  • Company has a consistent dividend-paying track record
  • Company maintains a comfortable, low leverage position

CONS

  • Recent results are weak - TTM profit is down 27.1% versus prior year
  • Company has a low return on equity of 7.8% over last 3 years
  • Company has a low return on capital employed of 10.1%
  • Company has delivered a poor profit growth of -16.0% over past five years
  • Valuation is stretched - P/E of 39.4 is well above its own 5-year median (21.9)
  • Company has delivered a poor sales growth of 6.7% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8525.0077.37226311.960.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1807.0089.3097634.420.113620.702139.4220263.101191.0018.2031.50
10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
12.KOPRAN203.9039.41984.541.476.70-10.04153.9913.886.6510.26
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023
117
111
Operating Profit
—
OPM %
—
Other Income
2
Interest
2
Depreciation
3
4
Tax %
23.27%
Net Profit
0
1
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
153
130
Operating Profit
—
OPM %
—
Other Income
0
Interest
2
Depreciation
3
18
Tax %
24.55%
Net Profit
0
3
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
159
135
Operating Profit
—
OPM %
—
Other Income
2
Interest
2
Depreciation
3
21
Tax %
22.96%
Net Profit
0
3
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
186
164
Operating Profit
—
OPM %
—
Other Income
10
Interest
3
Depreciation
4
25
Tax %
26.05%
Net Profit
0
4
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
139
121
Operating Profit
—
OPM %
—
Other Income
3
Interest
2
Depreciation
4
15
Tax %
24.71%
Net Profit
11
2
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
152
137
Operating Profit
—
OPM %
—
Other Income
1
Interest
2
Depreciation
4
10
Tax %
23.44%
Net Profit
7
2
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
166
146
Operating Profit
—
OPM %
—
Other Income
0
Interest
2
Depreciation
4
14
Tax %
24.96%
Net Profit
10
2
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
172
155
Operating Profit
—
OPM %
—
Other Income
3
Interest
3
Depreciation
4
14
Tax %
29.39%
Net Profit
10
2
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
135
121
Operating Profit
—
OPM %
—
Other Income
3
Interest
3
Depreciation
4
10
Tax %
24.67%
Net Profit
7
2
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
118
123
Operating Profit
—
OPM %
—
Other Income
0
Interest
2
Depreciation
4
-12
Tax %
14.62%
Net Profit
-10
-2
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
194
177
Operating Profit
—
OPM %
—
Other Income
0
Interest
3
Depreciation
4
11
Tax %
13.12%
Net Profit
9
2
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
234
201
Operating Profit
—
OPM %
—
Other Income
0
Interest
3
Depreciation
5
25
Tax %
25.56%
Net Profit
19
4
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
154
147
Operating Profit
—
OPM %
—
Other Income
2
Interest
3
Depreciation
6
9
Tax %
23.88%
Net Profit
7
0
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
310
274
Operating Profit
47
OPM %
15
Other Income
11
Interest
14
Depreciation
8
25
Tax %
20
Net Profit
20
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Mar 2018
313
284
Operating Profit
40
OPM %
13
Other Income
11
Interest
9
Depreciation
9
23
Tax %
10
Net Profit
20
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Mar 2019
358
312
Operating Profit
49
OPM %
14
Other Income
4
Interest
9
Depreciation
9
32
Tax %
24
Net Profit
24
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Mar 2020
359
313
Operating Profit
47
OPM %
13
Other Income
1
Interest
9
Depreciation
10
28
Tax %
26
Net Profit
21
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Mar 2021
492
410
Operating Profit
100
OPM %
20
Other Income
18
Interest
6
Depreciation
10
83
Tax %
26
Net Profit
62
EPS
14
Dividend Payout %
11
Minority Interest
0
Share of Associates
0
Adjusted EPS
14
Minority Interest
0
Share of Associates
0
Adjusted EPS
14
Mar 2022
478
390
Operating Profit
98
OPM %
21
Other Income
11
Interest
5
Depreciation
11
82
Tax %
25
Net Profit
61
EPS
14
Dividend Payout %
24
Minority Interest
0
Share of Associates
0
Adjusted EPS
13
Minority Interest
0
Share of Associates
0
Adjusted EPS
13
Mar 2023
551
499
Operating Profit
55
OPM %
10
Other Income
3
Interest
6
Depreciation
13
36
Tax %
24
Net Profit
27
EPS
6
Dividend Payout %
53
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Mar 2024
615
540
Operating Profit
89
OPM %
14
Other Income
15
Interest
9
Depreciation
13
68
Tax %
25
Net Profit
51
EPS
11
Dividend Payout %
28
Minority Interest
0
Share of Associates
0
Adjusted EPS
11
Minority Interest
0
Share of Associates
0
Adjusted EPS
11
Mar 2025
630
557
Operating Profit
77
OPM %
12
Other Income
4
Interest
9
Depreciation
16
52
Tax %
26
Net Profit
39
EPS
8
Dividend Payout %
38
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Mar 2026
681
619
Operating Profit
62
OPM %
9
Other Income
0
Interest
10
Depreciation
17
34
Tax %
25
Net Profit
26
EPS
5
Dividend Payout %
56
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
Minority Interest
0
Share of Associates
0
Adjusted EPS
5
TTM
700
648
Operating Profit
—
OPM %
—
Other Income
2
Interest
11
Depreciation
19
33
Tax %
25
Net Profit
25
EPS
—
Dividend Payout %
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—

COMPOUNDED SALES GROWTH

10 Years:
9%
5 Years:
7%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
9%
5 Years:
-16%
3 Years:
-2%

STOCK PRICE CAGR

10 Years:
15%
5 Years:
0%
3 Years:
3%
1 Year:
24%

RETURN ON EQUITY

10 Years:
14%
5 Years:
10%
3 Years:
8%
Last Year:
5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Aug 11

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2025

Sep 4

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2024

Sep 2

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2023

Sep 7

₹ 0.30

Rs.3.0000 per share(30%)Dividend

2022

Aug 4

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2021

Aug 5

₹ 0.15

Rs.1.5000 per share(15%)Final Dividend

2020

Nov 5

₹ 0.15

Interim Dividend

2026

Jul 17

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

Mar 2017
Equity Capital
43
81
56
Trade Payables
47
65
Total Liabilities
293
104
Capital Work in Progress
5
61
0
Cash & Bank
7
117
Total Assets
293
Total Debt
95
Net Working Capital
43
Contingent Liabilities
119
Book Value per Share
28.83
Face Value
10.00
Total Debt
95
Net Working Capital
43
Contingent Liabilities
119
Book Value per Share
28.83
Face Value
10.00
Mar 2018
Equity Capital
43
101
52
Trade Payables
61
54
Total Liabilities
312
104
Capital Work in Progress
7
71
0
Cash & Bank
6
123
Total Assets
312
Total Debt
89
Net Working Capital
58
Contingent Liabilities
121
Book Value per Share
33.46
Face Value
10.00
Total Debt
89
Net Working Capital
58
Contingent Liabilities
121
Book Value per Share
33.46
Face Value
10.00
Mar 2019
Equity Capital
43
125
45
Trade Payables
51
84
Total Liabilities
349
113
Capital Work in Progress
17
73
0
Cash & Bank
4
142
Total Assets
349
Total Debt
97
Net Working Capital
73
Contingent Liabilities
116
Book Value per Share
38.95
Face Value
10.00
Total Debt
97
Net Working Capital
73
Contingent Liabilities
116
Book Value per Share
38.95
Face Value
10.00
Mar 2020
Equity Capital
43
146
46
Trade Payables
55
80
Total Liabilities
370
111
Capital Work in Progress
22
88
0
Cash & Bank
5
144
Total Assets
370
Total Debt
88
Net Working Capital
83
Contingent Liabilities
42
Book Value per Share
43.86
Face Value
10.00
Total Debt
88
Net Working Capital
83
Contingent Liabilities
42
Book Value per Share
43.86
Face Value
10.00
Mar 2021
Equity Capital
43
202
43
Trade Payables
86
65
Total Liabilities
439
112
Capital Work in Progress
37
100
0
Cash & Bank
7
183
Total Assets
439
Total Debt
66
Net Working Capital
116
Contingent Liabilities
21
Book Value per Share
56.65
Face Value
10.00
Total Debt
66
Net Working Capital
116
Contingent Liabilities
21
Book Value per Share
56.65
Face Value
10.00
Mar 2022
Equity Capital
48
378
54
Trade Payables
62
69
Total Liabilities
611
151
Capital Work in Progress
28
150
0
Cash & Bank
57
226
Total Assets
611
Total Debt
75
Net Working Capital
263
Contingent Liabilities
41
Book Value per Share
88.40
Face Value
10.00
Total Debt
75
Net Working Capital
263
Contingent Liabilities
41
Book Value per Share
88.40
Face Value
10.00
Mar 2023
Equity Capital
48
391
56
Trade Payables
87
68
Total Liabilities
650
165
Capital Work in Progress
56
131
0
Cash & Bank
13
286
Total Assets
650
Total Debt
75
Net Working Capital
222
Contingent Liabilities
20
Book Value per Share
91.11
Face Value
10.00
Total Debt
75
Net Working Capital
222
Contingent Liabilities
20
Book Value per Share
91.11
Face Value
10.00
Mar 2024
Equity Capital
48
442
81
Trade Payables
113
59
Total Liabilities
743
182
Capital Work in Progress
78
138
212
Cash & Bank
14
119
Total Assets
743
Total Debt
99
Net Working Capital
235
Contingent Liabilities
18
Book Value per Share
101.68
Face Value
10.00
Total Debt
99
Net Working Capital
235
Contingent Liabilities
18
Book Value per Share
101.68
Face Value
10.00
Mar 2025
Equity Capital
48
468
129
Trade Payables
119
79
Total Liabilities
844
208
Capital Work in Progress
99
169
215
Cash & Bank
26
126
Total Assets
844
Total Debt
148
Net Working Capital
221
Contingent Liabilities
17
Book Value per Share
107.02
Face Value
10.00
Total Debt
148
Net Working Capital
221
Contingent Liabilities
17
Book Value per Share
107.02
Face Value
10.00
Mar 2026
Equity Capital
48
481
137
Trade Payables
158
85
Total Liabilities
908
346
Capital Work in Progress
2
164
263
Cash & Bank
7
125
Total Assets
908
Total Debt
153
Net Working Capital
177
Contingent Liabilities
19
Book Value per Share
109.54
Face Value
10.00
Total Debt
153
Net Working Capital
177
Contingent Liabilities
19
Book Value per Share
109.54
Face Value
10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
16
Cash from Investing
-18
Cash from Financing
2
-0
Free Cash Flow
16
OCF / Net Profit
0.80
Cumulative 5-Year FCF
0
OCF / Net Profit
0.80
Cumulative 5-Year FCF
0
Mar 2018
26
Cash from Investing
-11
Cash from Financing
-15
-0
Free Cash Flow
15
OCF / Net Profit
1.26
Cumulative 5-Year FCF
0
OCF / Net Profit
1.26
Cumulative 5-Year FCF
0
Mar 2019
25
Cash from Investing
-25
Cash from Financing
-1
-0
Free Cash Flow
-1
OCF / Net Profit
1.06
Cumulative 5-Year FCF
0
OCF / Net Profit
1.06
Cumulative 5-Year FCF
0
Mar 2020
31
Cash from Investing
-13
Cash from Financing
-18
0
Free Cash Flow
18
OCF / Net Profit
1.47
Cumulative 5-Year FCF
0
OCF / Net Profit
1.47
Cumulative 5-Year FCF
0
Mar 2021
60
Cash from Investing
-25
Cash from Financing
-35
0
Free Cash Flow
34
OCF / Net Profit
0.97
Cumulative 5-Year FCF
81
OCF / Net Profit
0.97
Cumulative 5-Year FCF
81
Mar 2022
-33
Cash from Investing
-84
Cash from Financing
123
5
Free Cash Flow
-73
OCF / Net Profit
-0.55
Cumulative 5-Year FCF
-8
OCF / Net Profit
-0.55
Cumulative 5-Year FCF
-8
Mar 2023
34
Cash from Investing
-13
Cash from Financing
-20
2
Free Cash Flow
-21
OCF / Net Profit
1.25
Cumulative 5-Year FCF
-44
OCF / Net Profit
1.25
Cumulative 5-Year FCF
-44
Mar 2024
43
Cash from Investing
-44
Cash from Financing
1
1
Free Cash Flow
-8
OCF / Net Profit
0.85
Cumulative 5-Year FCF
-51
OCF / Net Profit
0.85
Cumulative 5-Year FCF
-51
Mar 2025
42
Cash from Investing
-56
Cash from Financing
26
11
Free Cash Flow
-22
OCF / Net Profit
1.09
Cumulative 5-Year FCF
-91
OCF / Net Profit
1.09
Cumulative 5-Year FCF
-91
Mar 2026
67
Cash from Investing
-65
Cash from Financing
-21
-19
Free Cash Flow
9
OCF / Net Profit
2.59
Cumulative 5-Year FCF
-116
OCF / Net Profit
2.59
Cumulative 5-Year FCF
-116

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
EPS (₹)
4.60
Book Value (₹)
28.83
Dividend per Share (₹)
0.00
Cash EPS (₹)
6.53
Operating Margin %
14.68%
Net Margin %
6.25%
ROE %
17.71%
ROCE %
19.24%
7.15%
Debtor Days
74
Inventory Days
68
Payable Days
115
28
Debt to Equity (x)
0.76x
Interest Coverage (x)
2.81x
1.32x
Revenue Growth %
4.52%
Operating Profit Growth %
43.55%
Net Profit Growth %
85.77%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
4.74
Book Value (₹)
33.46
Dividend per Share (₹)
0.00
Cash EPS (₹)
6.71
Operating Margin %
12.71%
Net Margin %
6.51%
ROE %
15.21%
ROCE %
13.88%
6.77%
Debtor Days
80
Inventory Days
76
Payable Days
114
42
Debt to Equity (x)
0.61x
Interest Coverage (x)
3.66x
1.43x
Revenue Growth %
1.16%
Operating Profit Growth %
-14.52%
Net Profit Growth %
2.89%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
5.55
Book Value (₹)
38.95
Dividend per Share (₹)
0.00
Cash EPS (₹)
7.58
Operating Margin %
13.80%
Net Margin %
6.71%
ROE %
15.34%
ROCE %
16.30%
7.27%
Debtor Days
77
Inventory Days
74
Payable Days
107
44
Debt to Equity (x)
0.58x
Interest Coverage (x)
4.52x
1.54x
Revenue Growth %
14.23%
Operating Profit Growth %
23.50%
Net Profit Growth %
17.26%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
4.86
Book Value (₹)
43.86
Dividend per Share (₹)
0.00
Cash EPS (₹)
7.07
Operating Margin %
13.09%
Net Margin %
5.81%
ROE %
11.74%
ROCE %
13.69%
5.84%
Debtor Days
91
Inventory Days
82
Payable Days
100
72
Debt to Equity (x)
0.47x
Interest Coverage (x)
4.17x
1.59x
Revenue Growth %
0.45%
Operating Profit Growth %
-4.18%
Net Profit Growth %
-12.50%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
14.24
Book Value (₹)
56.65
Dividend per Share (₹)
1.50
Cash EPS (₹)
16.60
Operating Margin %
19.91%
Net Margin %
12.29%
ROE %
28.34%
ROCE %
30.40%
15.22%
Debtor Days
78
Inventory Days
69
Payable Days
91
56
Debt to Equity (x)
0.27x
Interest Coverage (x)
14.36x
1.72x
Revenue Growth %
36.81%
Operating Profit Growth %
110.80%
Net Profit Growth %
193.08%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
12.66
Book Value (₹)
88.40
Dividend per Share (₹)
3.00
Cash EPS (₹)
14.96
Operating Margin %
20.23%
Net Margin %
12.60%
ROE %
18.19%
ROCE %
21.40%
11.62%
Debtor Days
93
Inventory Days
94
Payable Days
109
79
Debt to Equity (x)
0.17x
Interest Coverage (x)
16.98x
2.74x
Revenue Growth %
-2.91%
Operating Profit Growth %
-1.77%
Net Profit Growth %
-0.93%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
5.65
Book Value (₹)
91.11
Dividend per Share (₹)
3.00
Cash EPS (₹)
8.29
Operating Margin %
9.83%
Net Margin %
4.88%
ROE %
6.29%
ROCE %
8.30%
4.32%
Debtor Days
95
Inventory Days
92
Payable Days
82
105
Debt to Equity (x)
0.17x
Interest Coverage (x)
6.93x
2.25x
Revenue Growth %
15.38%
Operating Profit Growth %
-44.02%
Net Profit Growth %
-55.38%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
10.57
Book Value (₹)
101.68
Dividend per Share (₹)
3.00
Cash EPS (₹)
13.24
Operating Margin %
12.10%
Net Margin %
8.29%
ROE %
10.96%
ROCE %
13.78%
7.32%
Debtor Days
111
Inventory Days
80
Payable Days
98
94
Debt to Equity (x)
0.20x
Interest Coverage (x)
8.86x
2.08x
Revenue Growth %
11.54%
Operating Profit Growth %
62.27%
Net Profit Growth %
87.11%
87.11%
P/E (x)
24.45x
P/B (x)
2.54x
Dividend Yield %
1.16%
14.95x
Mar 2025
EPS (₹)
7.98
Book Value (₹)
107.02
Dividend per Share (₹)
3.00
Cash EPS (₹)
11.21
Operating Margin %
11.58%
Net Margin %
6.12%
ROE %
7.66%
ROCE %
9.75%
4.86%
Debtor Days
124
Inventory Days
89
Payable Days
113
100
Debt to Equity (x)
0.29x
Interest Coverage (x)
6.56x
1.76x
Revenue Growth %
2.44%
Operating Profit Growth %
-13.64%
Net Profit Growth %
-24.34%
-24.46%
P/E (x)
21.93x
P/B (x)
1.64x
Dividend Yield %
1.71%
12.58x
Mar 2026
EPS (₹)
5.33
Book Value (₹)
109.54
Dividend per Share (₹)
3.00
Cash EPS (₹)
8.95
Operating Margin %
9.09%
Net Margin %
3.78%
ROE %
4.92%
ROCE %
6.65%
2.94%
Debtor Days
128
Inventory Days
89
Payable Days
123
94
Debt to Equity (x)
0.29x
Interest Coverage (x)
4.28x
1.51x
Revenue Growth %
8.23%
Operating Profit Growth %
-18.97%
Net Profit Growth %
-33.26%
-33.25%
P/E (x)
20.25x
P/B (x)
0.99x
Dividend Yield %
2.78%
10.70x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
44.49
0.68
0.14
Government
0.00
54.70
Sep 2024
44.49
1.31
0.22
Government
0.00
53.97
Dec 2024
44.46
0.86
0.00
Government
0.00
54.68
Mar 2025
44.42
1.11
0.00
Government
0.00
54.45
Jun 2025
44.42
0.76
0.00
Government
0.00
54.82
Sep 2025
44.42
0.60
0.00
Government
0.00
54.98
Dec 2025
44.42
0.36
0.00
Government
0.00
55.22
Mar 2026
44.42
0.57
0.00
Government
0.00
55.00
Jun 2026
44.42
0.51
0.00
Government
0.00
55.06

Documents

Announcements

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls

  • Aug 2026

    TranscriptPPTREC

  • May 2026

    TranscriptPPTREC

  • Jan 2026

    TranscriptPPTREC